Additionally, they documented that metformin induced switching properties in LGR4 isoforms that, collectively, support the hypothesis that metformin regulates HCC development by altering the alternative splicing of LGR4 [85]. The gene discussed is LGR4; the disease is hepatocellular carcinoma.